- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: human insulin
Total 6241 results
-
Assiut UniversityCompleted
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, India, Puerto Rico, Australia, Spain, Netherlands, Hungary, Brazil, Greece, Romania, Argentina
-
Massachusetts General HospitalCompletedDisorder of Bone Density and Structure, UnspecifiedUnited States
-
Centre Hospitalier Universitaire de BesanconEli Lilly and Company; AstraZenecaCompleted
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusSweden, Germany, Greece, Denmark, France
-
GeropharmCompletedBioequivalence | Therapeutic EquivalencyRussian Federation
-
FDA Office of Orphan Products DevelopmentChildren's Hospital of PhiladelphiaCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesKorea, Republic of, India, Malaysia, Turkey, Argentina, Greece, Australia, Portugal, Thailand, Brazil
-
University of CalgaryCompleted
-
Xijing HospitalXi'an Central Hospital; First Affiliated Hospital Xi'an Jiaotong University; Shaanxi... and other collaboratorsCompletedType 2 Diabetes MellitusChina
-
Taipei Veterans General Hospital, TaiwanUnknownType 2 DiabetesTaiwan
-
Abbott Diabetes CareCompletedDiabetes MellitusUnited Kingdom
-
Boston Children's HospitalInternational Rett Syndrome FoundationCompleted
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, Puerto Rico, Russian Federation, United Kingdom, Denmark, France, Israel, Australia, Romania
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, India, Russian Federation, Belgium, Spain, Israel, Croatia, Serbia, North Macedonia, South Africa, Slovenia, Brazil, Poland, Canada, Czechia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, France, Austria, Norway, Algeria
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Austria
-
Tulane University Health Sciences CenterCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, India, Russian Federation, Serbia, Turkey, Algeria, Czechia
-
Profil Institut für Stoffwechselforschung GmbHSanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, India, Israel, Russian Federation, Slovakia, Canada, Serbia, United Kingdom, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Poland, Finland, Belgium, Hungary, United Kingdom, Germany, Canada, Czechia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Malaysia, Germany, Algeria, Turkey
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, United States, India, Israel, Italy, Russian Federation, Japan, Finland, Serbia, Turkey, Bulgaria, Estonia, Czechia, Lithuania, Ukraine, Poland, Latvia, Puerto Rico
-
University of FloridaNovo Nordisk A/S; VA Office of Research and DevelopmentCompletedType 2 DiabetesUnited States
-
Novo Nordisk A/SCompleted
-
Northwestern UniversityCompletedHyperglycemia | Rejection | Evidence of Liver TransplantationUnited States
-
WockhardtCompletedDiabetes MellitusUnited States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Sweden, Norway, Germany, Australia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, France, Sweden, Poland, Turkey, Korea, Republic of, India, South Africa
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1India, Italy, United Kingdom, Finland, Japan, Argentina, Macedonia, The Former Yugoslav Republic of, Brazil
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Japan
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, United Kingdom, France, Netherlands, Finland, Germany, Sweden
-
Novo Nordisk A/SCompleted
-
Emory UniversityCompletedBenefits of Insulin Supplementation for Correction of Hyperglycemia in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2United States
-
Yale UniversityCompletedDiabetes Mellitus, Type I
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, India, Israel, Italy, Japan, Russian Federation, Canada, Austria, Taiwan, Serbia, Germany, Bulgaria, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States, Germany
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Russian Federation, United Kingdom, Denmark, Netherlands, Norway, South Africa, Finland, France, Spain, Former Serbia and Montenegro, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, France, Argentina, Macedonia, The Former Yugoslav Republic of, Slovenia, Canada, Brazil
-
SanofiCompletedDiabetes Mellitus, Type 1France
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, Austria, South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Sweden, Finland, France, Norway
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Spain, France, Norway, Romania
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Canada, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1China
-
Tonghua Dongbao Pharmaceutical Co.,LtdCompleted